BILEX TAB 100 MG
PHENOLPHTHALEIN : 100 MG BILE SALTS : 60 MG CASCARA SAGRADA : 30 MG ALOIN : 12 MG · DIN 00426237 · BIODO ENRG
Health Canada status: CANCELLED POST MARKET
What is BILEX TAB?
BILEX TAB 100 MG contains PHENOLPHTHALEIN : 100 MG BILE SALTS : 60 MG CASCARA SAGRADA : 30 MG ALOIN : 12 MG. It is listed in the Health Canada Drug Product Database under DIN 00426237, held by BIODO ENRG, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 10-Oct-1997. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00426237 |
|---|---|
| Brand name | BILEX TAB |
| Generic / active ingredient | PHENOLPHTHALEIN : 100 MG BILE SALTS : 60 MG CASCARA SAGRADA : 30 MG ALOIN : 12 MG |
| Manufacturer | BIODO ENRG |
| Strength | 100 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A06AB20 CONTACT LAXATIVES IN COMBINATION |
| AHFS class | 56:12.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 10-Oct-1997 |
| Original market date | 1978-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A06AB20 CONTACT LAXATIVES IN COMBINATION. 0 of 60 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AID-LAX TAB | 12 MG | TABLET | NOBEL PHARM ENR. | CANCELLED POST MARKET | DIN 00750212 |
| ALSILINE | 60 MG | TABLET | ALSI CIE LTEE | CANCELLED POST MARKET | DIN 00445258 |
| BEKUNIS DRAGEES | 5 MG | TABLET | ROHA ARZNEIMITTEL GMBH | CANCELLED POST MARKET | DIN 00402435 |
| BICHOLATE LILAS | 5 MG | TABLET | SABEX INC | CANCELLED POST MARKET | DIN 02236732 |
| BICHOLATE LILAS TAB | 100 MG | TABLET | SABEX INC | CANCELLED POST MARKET | DIN 00888648 |
| C OTTWAYS LAX TAB | 28 MG | TABLET | C OTTWAY HERBALIST | CANCELLED POST MARKET | DIN 00329398 |
| CARTERS LITTLE PILLS TAB | 16 MG | TABLET | CARTER PRODUCTS, DIVISION OF CARTER WALLACE NS INC. | CANCELLED POST MARKET | DIN 00411817 |
| CHOLASYN | 50 MG | TABLET | ROLMEX INTERNATIONAL INC. | CANCELLED POST MARKET | DIN 02236803 |
| CHOLASYN II | 25 MG | TABLET | ROLMEX INTERNATIONAL INC. | CANCELLED POST MARKET | DIN 00499447 |
| COMPRIMES LAXATIFS | 240 MG | TABLET | LE NATURISTE J.M.B. INC. | CANCELLED POST MARKET | DIN 00484881 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.